Simultaneous Bilateral Radiofrequency Thalamotomy for Medication-Refractory Essential Tremor

Recruiting N/A Interventional Study
Essential Tremor
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
20 – 70
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
5 (estimated)
Sponsor
Tokyo Women's Medical University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study aims to evaluate the safety and effectiveness of simultaneous bilateral radiofrequency thalamotomy for patients with medication-refractory essential tremor (ET). Essential tremor is a common neurological condition that causes involuntary shaking, often affecting the hands and interfering with daily activities such as writing, eating, or using tools. While medications such as propranolol…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults aged 20 to 70 years. * Diagnosis of essential tremor by a neurologist or neurosurgeon specializing in movement disorders. * Refractory to standard pharmacological therapy (e.g., propranolol, primidone, benzodiazepines, or alprenolol). * Mini-Mental State Examination (MM…
Contacts

SHIRO Horisawa, MD

+81333538111

neurosurgery0222@gmail.com

CONTACT